Wenfeng Zhang

ORCID: 0000-0002-6113-0285 · 1 paper in corpus

article 2020

Levonorgestrel Ameliorates Adenomyosis via lncRNA H19/miR-17/TLR4 Pathway

Drug design, development and therapy ·doi:10.2147/dddt.s248095

PURPOSE: To explore the mechanism of levonorgestrel (LNG)-ameliorating adenomyosis through long non-coding RNA H19 (lncRNA H19)/miR-17/Toll-like receptor 4 (TLR4) pathway. PATIENTS AND METHODS: A total of 71 cases of adenomyosis and 54 case…